Clinical Trials for Akesobio

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Akesobio

Clinical Trials (8)

NCT07208773
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
PHASE1/PHASE2Not yet recruiting
260 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06959550
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
PHASE2Recruiting
90 participants
Started: Jul 28, 2025 · Completed: Jul 1, 2030
1 condition3 sponsors1 location
NCT06936644
A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation
PHASE2Not yet recruiting
39 participants
Started: Apr 30, 2025 · Completed: Mar 30, 2028
1 condition3 sponsors0 locations
NCT06789848
Ligufalimab and Cadonilimab in Advanced Liver Cancers
PHASE2Recruiting
64 participants
Started: Feb 18, 2025 · Completed: May 31, 2030
3 conditions3 sponsors1 location
NCT06491472
Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
PHASE2Recruiting
36 participants
Started: Jul 15, 2024 · Completed: Jul 15, 2027
1 condition2 sponsors1 location
NCT06416930
Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma
PHASE2Not yet recruiting
59 participants
Started: Jun 20, 2024 · Completed: Jun 20, 2029
1 condition2 sponsors0 locations
NCT06187961
Combined HAIC, Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma
PHASE2Recruiting
36 participants
Started: Dec 7, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05021120
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
EARLY_PHASE1Active, not recruiting
66 participants
Started: Oct 12, 2021 · Completed: May 27, 2025
1 condition1 sponsor5 locations